Aflac, Inc.

  • Market Cap: Large Cap
  • Industry: Insurance
  • ISIN: US0010551028
USD
109.24
0.2 (0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.19 M

Shareholding (Mar 2025)

FII

22.91%

Held by 360 FIIs

DII

47.16%

Held by 61 DIIs

Promoter

9.57%

How big is Aflac, Inc.?

22-Jun-2025

As of Jun 18, Aflac, Inc. has a market capitalization of $125.61 billion, with net profit of $3.59 billion over the last four quarters and total assets of $117.40 billion.

As of Jun 18, Aflac, Inc. has a market capitalization of 125,610.51 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is 3,593.00 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 26,098.00 million and Total Assets at 117,403.00 million.

Read More

What does Aflac, Inc. do?

22-Jun-2025

Aflac, Inc. is a large-cap holding company specializing in supplemental health and life insurance. As of March 2025, it has a market cap of approximately $125.61 billion and reported a net profit of $29 million.

Overview:<BR>Aflac, Inc. is a business holding company involved in supplemental health and life insurance, operating within the insurance industry and categorized as a large-cap company.<BR><BR>Financial Snapshot:<BR>- Net Profit: 29 Million (Quarterly Results - Mar 2025)<BR>- Market Cap: USD 125,610.51 Million (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 36.00<BR>- Dividend Yield: 1.02%<BR>- Debt Equity: -999,999.00<BR>- Return on Equity: 13.64%<BR>- Price to Book: 4.77<BR><BR>Contact Details:<BR>- Address: 1932 WYNNTON RD, COLUMBUS GA: 31999<BR>- Tel: 1 706 3233431<BR>- Website: https://www.aflac.com/

Read More

Who are in the management team of Aflac, Inc.?

22-Jun-2025

As of March 2022, Aflac, Inc.'s management team includes Chairman and CEO Daniel Amos, Lead Independent Director W. Paul Bowers, and Independent Directors Toshihiko Fukuzawa, Thomas Kenny, Georgette Kiser, and Karole Lloyd, who collectively guide the company's strategic direction and governance.

As of March 2022, the management team of Aflac, Inc. includes the following members:<BR><BR>- Mr. Daniel Amos: Chairman of the Board, Chief Executive Officer<BR>- Mr. W. Paul Bowers: Lead Independent Director<BR>- Mr. Toshihiko Fukuzawa: Independent Director<BR>- Mr. Thomas Kenny: Independent Director<BR>- Ms. Georgette Kiser: Independent Director<BR>- Mrs. Karole Lloyd: Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is Aflac, Inc. overvalued or undervalued?

20-Sep-2025

As of August 5, 2025, Aflac, Inc. is considered very expensive with a high P/E ratio of 36 and other valuation metrics indicating overvaluation compared to peers like Progressive Corp. and MetLife, despite its strong long-term performance.

As of 5 August 2025, the valuation grade for Aflac, Inc. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 4.84, and an EV to Capital Employed ratio of 4.75. In comparison, Progressive Corp. has a P/E of 18.83 and MetLife, Inc. has a P/E of 18.69, both indicating that Aflac is trading at a premium relative to its peers.<BR><BR>Despite a strong performance over the long term, with a 5-year return of 185.71% compared to the S&P 500's 96.61%, Aflac's recent returns have lagged behind the index, particularly in the 1-year period where it returned -0.88% versus the S&P 500's 17.14%. This suggests that while the company has historically performed well, its current valuation may not be justified given its recent performance and comparison to industry peers.

Read More

Is Aflac, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Aflac, Inc. shows a mildly bullish trend with mixed signals from MACD and moving averages, having underperformed the S&P 500 over the past year but outperformed in the 3- and 5-year periods.

As of 12 September 2025, the technical trend for Aflac, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Moving averages indicate a mildly bearish trend on the daily chart. Dow Theory supports a mildly bullish trend on both weekly and monthly time frames. <BR><BR>In terms of performance, Aflac has underperformed the S&P 500 over the past year with a return of -0.88% compared to the S&P 500's 17.14%, but it has outperformed over the 3-year and 5-year periods. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 17.89%

 
2

The company declared negative results in Mar'25 after positive results in Dec'24

3

With ROE of 13.64%, it has a expensive valuation with a 4.84 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 130,221 Million (Large Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.02%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

8.96%

stock-summary
Price to Book

4.79

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
599 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.64%
0%
0.64%
6 Months
6.23%
0%
6.23%
1 Year
2.1%
0%
2.1%
2 Years
32.04%
0%
32.04%
3 Years
51.01%
0%
51.01%
4 Years
101.25%
0%
101.25%
5 Years
135.99%
0%
135.99%

Aflac, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-6.03%
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
18.17%
Dividend Payout Ratio
20.76%
Pledged Shares
0
Institutional Holding
69.14%
ROCE (avg)
0
ROE (avg)
17.89%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
4.84
EV to EBIT
NA
EV to EBITDA
EV to Capital Employed
4.75
EV to Sales
7.59
PEG Ratio
NA
Dividend Yield
1.01%
ROCE (Latest)
ROE (Latest)
13.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 147 Schemes (20.35%)

Foreign Institutions

Held by 360 Foreign Institutions (22.91%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1,965.52% vs -98.48% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "52.00",
          "val2": "50.00",
          "chgp": "4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "599.00",
          "val2": "29.00",
          "chgp": "1,965.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "210.10%",
          "val2": "57.40%",
          "chgp": "15.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.83% vs 5.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.00",
          "val2": "39.00",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "197.00",
          "val2": "195.00",
          "chgp": "1.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,443.00",
          "val2": "4,659.00",
          "chgp": "16.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "349.40%",
          "val2": "291.80%",
          "chgp": "5.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.00
0.00
Interest
52.00
50.00
4.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
599.00
29.00
1,965.52%
Operating Profit Margin (Excl OI)
210.10%
57.40%
15.27%
USD in Million.
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 1,965.52% vs -98.48% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
40.00
39.00
2.56%
Interest
197.00
195.00
1.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,443.00
4,659.00
16.83%
Operating Profit Margin (Excl OI)
349.40%
291.80%
5.76%
USD in Million.
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.83% vs 5.45% in Dec 2023

stock-summaryCompany CV
About Aflac, Inc. stock-summary
stock-summary
Aflac, Inc.
Insurance
Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.
Company Coordinates stock-summary
Company Details
1932 WYNNTON RD , COLUMBUS GA : 31999
stock-summary
Tel: 1 706 3233431
stock-summary
Registrar Details